196 related articles for article (PubMed ID: 3035479)
1. Nabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children: a double-blind, crossover trial.
Chan HS; Correia JA; MacLeod SM
Pediatrics; 1987 Jun; 79(6):946-52. PubMed ID: 3035479
[TBL] [Abstract][Full Text] [Related]
2. Double-blind comparison of the antiemetic effects of nabilone and prochlorperazine on chemotherapy-induced emesis.
Steele N; Gralla RJ; Braun DW; Young CW
Cancer Treat Rep; 1980; 64(2-3):219-24. PubMed ID: 6250699
[TBL] [Abstract][Full Text] [Related]
3. Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy.
Herman TS; Einhorn LH; Jones SE; Nagy C; Chester AB; Dean JC; Furnas B; Williams SD; Leigh SA; Dorr RT; Moon TE
N Engl J Med; 1979 Jun; 300(23):1295-7. PubMed ID: 375088
[TBL] [Abstract][Full Text] [Related]
4. Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine.
Sallan SE; Cronin C; Zelen M; Zinberg NE
N Engl J Med; 1980 Jan; 302(3):135-8. PubMed ID: 6985702
[TBL] [Abstract][Full Text] [Related]
5. Antiemetic efficacy of dexamethasone. Randomized, double-blind, crossover study with prochlorperazine in patients receiving cancer chemotherapy.
Markman M; Sheidler V; Ettinger DS; Quaskey SA; Mellits ED
N Engl J Med; 1984 Aug; 311(9):549-52. PubMed ID: 6379459
[TBL] [Abstract][Full Text] [Related]
6. Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9-tetrahydrocannabinol.
Ekert H; Waters KD; Jurk IH; Mobilia J; Loughnan P
Med J Aust; 1979 Dec; 2(12):657-9. PubMed ID: 231736
[TBL] [Abstract][Full Text] [Related]
7. Nabilone in the management of prochlorperazine resistant cancer chemotherapy induced emesis.
Niamatali C; Fallon SD; Egan EL
Ir Med J; 1984 Sep; 77(9):276-7. PubMed ID: 6090342
[No Abstract] [Full Text] [Related]
8. Double-blind crossover trial of droperidol, metoclopramide, and prochlorperazine as antiemetics in cisplatin therapy.
Lewis GO; Bernath AM; Ellison NM; Gallagher JG; Porter PA; Rine KT
Clin Pharm; 1984; 3(6):618-21. PubMed ID: 6391784
[TBL] [Abstract][Full Text] [Related]
9. Antiemetic efficacy of levonantradol compared to delta-9-tetrahydrocannabinol for chemotherapy-induced nausea and vomiting.
Citron ML; Herman TS; Vreeland F; Krasnow SH; Fossieck BE; Harwood S; Franklin R; Cohen MH
Cancer Treat Rep; 1985 Jan; 69(1):109-12. PubMed ID: 2981616
[TBL] [Abstract][Full Text] [Related]
10. Nabilone and high-dose metoclopramide: anti-emetics for cancer chemotherapy.
Drug Ther Bull; 1984 Feb; 22(3):9-11. PubMed ID: 6321126
[No Abstract] [Full Text] [Related]
11. Nabilone: an effective antiemetic in patients receiving cancer chemotherapy.
Einhorn LH; Nagy C; Furnas B; Williams SD
J Clin Pharmacol; 1981; 21(S1):64S-69S. PubMed ID: 6271844
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, controlled trial of nabilone vs. prochlorperazine for refractory emesis induced by cancer chemotherapy.
Johansson R; Kilkku P; Groenroos M
Cancer Treat Rev; 1982 Dec; 9 Suppl B():25-33. PubMed ID: 6299551
[No Abstract] [Full Text] [Related]
13. Antiemetic efficacy of prochlorperazine, haloperidol, and droperidol in cisplatin-induced emesis.
Owens NJ; Schauer AR; Nightingale CH; Golub GR; Martin RS; Williams HM; Schauer PK
Clin Pharm; 1984; 3(2):167-70. PubMed ID: 6373102
[TBL] [Abstract][Full Text] [Related]
14. [Randomized comparative trial of a new anti-emetic: nabilone, in cancer patients treated with cisplatin].
George M; Pejovic MH; Thuaire M; Kramar A; Wolff JP
Biomed Pharmacother; 1983; 37(1):24-7. PubMed ID: 6311306
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of oral granisetron versus oral prochlorperazine in preventing nausea and emesis in patients receiving moderately emetogenic chemotherapy.
Burris H; Hesketh P; Cohn J; Moriconi W; Ryan T; Friedman C; Fitts D
Cancer J Sci Am; 1996; 2(2):85-90. PubMed ID: 9166505
[TBL] [Abstract][Full Text] [Related]
16. A cross-over comparison of nabilone and prochlorperazine for emesis induced by cancer chemotherapy.
Niiranen A; Mattson K
Am J Clin Oncol; 1985 Aug; 8(4):336-40. PubMed ID: 3002167
[TBL] [Abstract][Full Text] [Related]
17. Randomized, double-blind, cross-over study comparing prochlorperazine and lorazepam with high-dose metoclopramide and lorazepam for the control of emesis in patients receiving cytotoxic chemotherapy.
Bishop JF; Wolf M; Matthews JP; Scott K; Ackland S; Yuen K; Morton C; Hillcoat BL; Cooper IA
Cancer Treat Rep; 1987 Nov; 71(11):1007-11. PubMed ID: 3315193
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues.
Cunningham D; Bradley CJ; Forrest GJ; Hutcheon AW; Adams L; Sneddon M; Harding M; Kerr DJ; Soukop M; Kaye SB
Eur J Cancer Clin Oncol; 1988 Apr; 24(4):685-9. PubMed ID: 2838294
[TBL] [Abstract][Full Text] [Related]
19. Nabilone and prochlorperazine: a useful combination for emesis induced by cytotoxic drugs.
Cunningham D; Forrest GJ; Soukop M; Gilchrist NL; Calder IT; McArdle CS
Br Med J (Clin Res Ed); 1985 Sep; 291(6499):864-5. PubMed ID: 2996690
[No Abstract] [Full Text] [Related]
20. Double-blind multiple-dose crossover study of the antiemetic effect of intramuscular levonantradol compared to prochlorperazine.
Sheidler VR; Ettinger DS; Diasio RB; Enterline JP; Brown MD
J Clin Pharmacol; 1984 Apr; 24(4):155-9. PubMed ID: 6373843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
